English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson’s Disease Models of Caenorhabditis elegans Journal article
He, Li, Du, Jing Jing, Zhou, Jun Jie, Chen, Meng Ting, Luo, Lu, Li, Bao Qiong, Zhang, Xiang Zhi, Ma, Wen Zhe, Ma, Ai Jun, Feng, Na. Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson’s Disease Models of Caenorhabditis elegans[J]. Frontiers in Chemistry, 2022, 10.
Authors:  He, Li;  Du, Jing Jing;  Zhou, Jun Jie;  Chen, Meng Ting;  Luo, Lu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:10  IF:3.8/4.8 | Submit date：2023/01/30
Antioxidant Activity  C. Elegans  Derivative Of Melatonin  Parkinson’s Disease  Synthesis  
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer’s disease Review article
2022
Authors:  Shen, Shengnan;  Liao, Qiwen;  Wong, Yin Kwan;  Chen, Xiao;  Yang, Chuanbin; et al.
Favorite | TC[WOS]:35 TC[Scopus]:36  IF:8.2/8.3 | Submit date：2022/05/17
Alzheimer’s Disease  Anti-inflammatory  Insulin Resistance  Melatonin  Mitochondria  Type 2 Diabetes  
Melatonergic agents in the prevention of delirium: A network meta-analysis of randomized controlled trials Review article
2020
Authors:  Yang,Chun Pai;  Tseng,Ping Tao;  Pei-Chen Chang,Jane;  Su,Huanxing;  Satyanarayanan,Senthil Kumaran; et al.
Favorite | TC[WOS]:28 TC[Scopus]:32  IF:11.2/12.7 | Submit date：2021/03/01
Delirium  Melatonin  Melatonin Agonist  Prevention  Ramelteon  
Circadian rhythm and melatonin in the treatment of depression Journal article
Satyanarayanan,Senthil Kumaran, Su,Huanxing, Lin,Yi Wen, Su,Kuan Pin. Circadian rhythm and melatonin in the treatment of depression[J]. Current Pharmaceutical Design, 2018, 24(22), 2549-2555.
Authors:  Satyanarayanan,Senthil Kumaran;  Su,Huanxing;  Lin,Yi Wen;  Su,Kuan Pin
Favorite | TC[WOS]:60 TC[Scopus]:69  IF:2.6/3.0 | Submit date：2021/03/01
Antidepressants  Circadian Rhythm  Depression  Melatonin  Melatonin Receptor Agonists  Pharmacology  
Adjunctive melatonin for tardive dyskinesia in patients with schizophrenia: a meta-analysis Journal article
Sun,Chen Hui, Zheng,Wei, Yang,Xin Hu, Cai,Dong Bin, Ng,Chee H., Ungvari,Gabor S., Li,Hai Yan, Wu,Yu Jie, Ning,Yu Ping, Xiang,Yu Tao. Adjunctive melatonin for tardive dyskinesia in patients with schizophrenia: a meta-analysis[J]. Shanghai Archives of Psychiatry, 2017, 29(3), 129-136.
Authors:  Sun,Chen Hui;  Zheng,Wei;  Yang,Xin Hu;  Cai,Dong Bin;  Ng,Chee H.; et al.
Favorite | TC[Scopus]:7
Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease Journal article
Wang, Yuan-Yuan, Zheng, Wei, Ng, Chee H., Ungvari, Gabor S., Wei, Wei, Xiang, Yu-Tao. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease[J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32(1), 50-57.
Authors:  Wang, Yuan-Yuan;  Zheng, Wei;  Ng, Chee H.;  Ungvari, Gabor S.;  Wei, Wei; et al.
Favorite | TC[WOS]:54 TC[Scopus]:59  IF:3.6/3.9 | Submit date：2018/10/31
Alzheimer's Disease  Melatonin  Meta-analysis  Placebo